News | September 06, 2022
Aurionpro acquires US based startup Hello Patients
Hello Patients provides healthcare billing and patients’ management solution
Hello Patients provides healthcare billing and patients’ management solution
The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.
Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins
The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
Subscribe To Our Newsletter & Stay Updated
